Michael J. McRae

Michael McRae practices at St. Luke's Nampa Medical Center in Nampa, Idaho, part of St. Luke's Health System.

Michael McRae's NPI, 1043745805, was assigned on April 28, 2017. Michael McRae graduated from University of North Texas Hsc, College of Osteopathic Med in 2017. Michael McRae holds Idaho license MRO-1628.

Michael McRae's primary practice is St. Luke's Nampa Medical Center, at 9850 West St Lukes Drive, Nampa, ID 83687 in Canyon County. The practice phone is (208) 505-2000.

Michael McRae's primary practice is St. Luke's Nampa Medical Center in Nampa, Idaho, part of St. Luke's Health System. Michael McRae is also affiliated with St. Luke's Boise Medical Center. The medical group on file is St. Luke's Health System. Dmand AI also links Michael McRae to 2 more home health agencies and 1 community health center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Michael McRae practices, 5 sites in all. Vendor and product names are available with a free account.

Family medicine is Michael McRae's primary specialty in the NPI Registry, under taxonomy code 207Q00000X. Michael McRae is licensed in Idaho.

CMS data shows 798 Medicare services from Michael McRae across 5 procedure codes in 2024, for 194 Medicare patients. Medicare paid $28,920 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 194 Medicare patients who saw Michael McRae in 2024. The largest group is 65 to 74, with 103 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 10% are also on Medicaid. Their average risk score is 1.37, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Michael McRae's median patient age at 67, with 52% women.

In 2024, Michael McRae wrote 7,628 Medicare Part D claims for 547 patients. 81% of them were for generic drugs. CMS names the drug for 6,792 of them, across 126 drugs with 11 or more claims each, at $1,130,474 in total drug cost. In 2023, CMS named 4,884 claims across 112 drugs.

Michael McRae accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Michael McRae as offering telehealth.

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 1 paper to Michael McRae in 2022. Michael McRae's most frequent co-author is Cecilia Chiacheh Low Wang, MD.

CMS Open Payments shows 42 general payments to Michael McRae from 9 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 62% of the total. Medtronic, Inc. paid the most, $1,471.

Michael McRae graduated from University of North Texas Hsc, College of Osteopathic Med in 2017.